Dive Brief: The Food and Drug Administration has rejected Eli Lilly’s request to approve an experimental ulcerative colitis drug due to manufacturing issues, delaying the …
Merck & Co. has reached a deal to acquire Prometheus Biosciences for about $10.8 billion, betting an experimental drug the biotechnology company is developing will …
Biotech Fluidics reports that the biocompatible flow path and minimal heat output of its Runge Mikron detectors makes them perfect for analysis and preparative purification …
After successfully launching the SONOFLOW® CO.55 V3.0 flow meter last year, SONOTEC presents new sensor sizes to cover a wider range of biopharmaceutical applications. Designed …
Dive Brief: Bluebird bio is likely to miss its goal for submitting an experimental gene therapy for sickle cell disease to the Food and Drug …
Sartorius, a Germany-based manufacturer and supplier to the biopharmaceutical industry, is acquiring France’s Polyplus in a $2.6 billion acquisition meant to expand the company’s role …
Vedere Bio II, a startup launched two years ago to develop gene therapies for the eye, is winding down. In a message posted on LinkedIn …
Biotech Fluidics has announced the highly efficient degassers optimized for Gel Permeation Chromatography (GPC) applications – the DEGASi Plus GPC and DEGASi Plus GPC Semi-Prep. …
The round is co-led by M Ventures and Debiopharm Innovation Fund with Omnes Capital; all joining as new investors Series A will enable Iktos to …
After 25 years as CEO of PTC Therapeutics, Stuart Peltz is stepping down from his role as head of the rare disease drugmaker. The company announced …
Dive Brief: An anti-inflammatory drug from Sanofi and Regeneron succeeded in a Phase 3 clinical trial in chronic obstructive pulmonary disease, giving the medicine, Dupixent, …
Nearly one year after being ousted as CEO of Seagen, Clay Siegall is back at the helm of a biotechnology company. On Thursday, he was …
The rapid demise of Silicon Valley Bank put an unwelcome spotlight on the financial position of many small biotechnology companies that relied on the storied …
Dive Brief: The Food and Drug Administration will convene a panel of experts to review Sarepta Therapeutics’ application for approval of a muscular dystrophy gene …
Dive Brief: An experimental Merck & Co. drug that pairs Keytruda with a new type of immunotherapy did not help people with lung cancer in …
Pfizer’s planned $43 billion acquisition of Seagen will be a major test for the Federal Trade Commission since the monopoly-regulating agency revised its views of …
Three months ago, Japanese pharmaceutical giant Takeda paid a biotechnology startup $4 billion for an experimental drug in one of the largest deals of its …
Dive Brief: Sanofi said Thursday it will cut the prices for its insulin products by as much as 78%, following two of its rivals who …
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies PCI Pharma Services (PCI), a …
Though the FDA has long been aware of the risk that some people with breast implants may develop a rare form of T-cell lymphoma—now known …
